This Align Technology Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure

DENTSPLY SIRONA (XRAY) exceeded Q2 earnings and revenue estimates with adjusted EPS of 52 cents versus 36 cents consensus, though revenues fell 4.1% year-over-year. The company maintained full-year 2026 guidance of $3.5-3.6B in sales and $1.40-1.50 adjusted EPS. Wellspect Healthcare grew 7.1%, but three dental segments declined, with tariff pressures and lower volumes constraining operating margins. Free cash flow improved to $55M from $16M year-ago.

SanDisk Rips 10%, Micron Rises 6% as AI Memory Frenzy Builds: Stock Market Today

Memory chipmakers ripped higher Monday after Washington pushed Apple away from Chinese DRAM suppliers, while the 30-year yield hit a fresh 19-year peak.

Reported Earlier, Align Technology Secures China Patent Win Against Angelalign, Following Prior UPC And Pending ITC Rulings

Align Technology shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance with its midpoint below estimates.

Shares of chip companies are trading higher amid overall market strength, falling yields and declining oil prices. The industry may be boosted by recent talks between Intel and SK Hynix regarding U.S. chip manufacturing.

Shares of semiconductor and chip-related companies are trading lower after AI executives signaled that the industry's growth may need to be slowed. The industry is also facing pressure as oil prices spike in reaction to the escalating conflict in the Middle East which can lead to inflation, tighter lending and reduced demand.